10 X Genomics Inc (TXG)

10 X Genomics Inc Azioni (TXG) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	23.36% 141.01	183.98	153.64	146.82	134.28
Cost Of Revenue	29.48% 48.09	68.20	58.12	47.21	35.90
Gross Profit	19.75% 92.91	115.78	95.53	99.61	98.39
Operating Expenses	9.68% 154.41	170.97	190.32	162.97	150.38
Interest Income/Expense	87.50% 0.001	0.008	0.001	0.005	0.019
Benefits Costs and Expenses	13.78% 198.81	230.58	245.39	207.59	183.94
Costs And Expenses	13.78% 198.81	230.58	245.39	207.59	183.94
Operating Income/Loss	11.43% -61.50	-55.19	-94.80	-63.36	-51.99
Nonoperating Income/Loss	56.98% 3.695	8.59	3.051	2.591	2.334
Income/Loss From Continuing Operations Before Tax	24.05% -57.80	-46.60	-91.74	-60.77	-49.65
Income Tax Expense/Benefit	8.84% 2.146	2.354	1.242	1.647	1.093
Income/Loss From Continuing Operations After Tax	22.46% -59.95	-48.95	-92.99	-62.41	-50.75
Net Income/Loss	22.46% -59.95	-48.95	-92.99	-62.41	-50.75
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	25,194% 119.39	0.472	117.73	116.71	115.62
Diluted Average Shares	25,194% 119.39	0.472	117.73	116.71	115.62
Basic Earnings Per Share	21.95% -0.50	-0.41	-0.79	-0.53	-0.44
Diluted Earnings Per Share	21.95% -0.50	-0.41	-0.79	-0.53	-0.44
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-